Moderna Inc <MRNA.O>: UBS raises target price to $150 from $50
MRNA•Related News
Apeiron Investment Group reports acquisition of Enhanced Group common shares worth $2.92 million
ENHA•
Nurix Therapeutics names Wes Burwell chief human resources officer
NRIX•
Fractyl Health spotlights REMAIN-1 data showing Revita maintains 84% of GLP-1 weight loss in optimized cohort
GUTS•
Viking Holdings Ltd <VIK.N>: Stifel cuts target price to $120 from $125
VIK•
Lands’ End schedules conference call on fiscal Q2 2026 results
LE•